30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Maze Therapeutics Inc (MAZE)

Track

Over the last 90 days, Maze Therapeutics Inc. has seen significant insider selling activity, with a total sell value exceeding $6.4 million. Notably, executives like Jason V. Coloma and Harold Bernstein have engaged in multiple planned and proposed sales. This activity coincides with a substantial stock price decline of over 53% in the past 90 days, with the stock trading near its 52-week low.
Stock chart
Ticker: MAZE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Bernstein Harold
President, R&D & CMO
2 sales — total 200,000 USD
Planned sale 1 Jun 2026
Value US$2,421,769.84 | Price 109.34 | Shares 40,640
Planned sale 1 Jun 2026
Value US$3,423,798.96 | Price 237.30 | Shares 52,490
Planned sale 1 Jun 2026
Value US$4,141,047.85 | Price 486.22 | Shares 4,608
Planned sale 1 Jun 2026
Value US$4,106,235.16 | Price 106.81 | Shares 95,990
Proposed sale 1 Jun 2026
Value US$908,066.32 | Price 26.32 | Shares 34,501
Planned sale 29 May 2026
Value US$100,000.00 | Price 26.34 | Shares 1,000
Planned sale 26 May 2026
Value US$665,515.73 | Price 26.02 | Shares 25,582
Planned sale 22 May 2026
Value US$64,428.00 | Price 26.00 | Shares 2,478
Planned sale 22 May 2026
Value US$117,104.45 | Price 26.00 | Shares 4,504
Planned sale 15 May 2026
Value US$3,016.00 | Price 26.00 | Shares 116
Planned sale 15 May 2026
Value US$47,372.00 | Price 26.00 | Shares 1,822
Proposed sale 15 May 2026
Value US$895,326.90 | Price 25.95 | Shares 34,502
Planned sale 14 May 2026
Value US$393,354.00 | Price 26.22 | Shares 15,000
Planned sale 29 Apr 2026
Value US$190,299.00 | Price 25.37 | Shares 7,500
Planned sale 1 Apr 2026
Value US$9,101.01 | Price 30.34 | Shares 300
Planned sale 1 Apr 2026
Value US$9,101.01 | Price 30.34 | Shares 300
Planned sale 1 Apr 2026
Value US$64,509.94 | Price 29.32 | Shares 2,200
Planned sale 1 Apr 2026
Value US$64,509.94 | Price 29.32 | Shares 2,200
Planned sale 1 Apr 2026
Value US$9,320.01 | Price 31.07 | Shares 300
Planned sale 1 Apr 2026
Value US$100,635.86 | Price 30.06 | Shares 3,348
Planned sale 1 Apr 2026
Value US$331,948.37 | Price 29.24 | Shares 11,352
Planned sale 30 Mar 2026
Value US$23,713.67 | Price 30.02 | Shares 790
Planned sale 30 Mar 2026
Value US$196,305.08 | Price 29.26 | Shares 6,710
Proposed sale 30 Mar 2026
Value US$911,400.00 | Price 30.38 | Shares 30,000
Planned sale 20 Mar 2026
Value US$252,293.82 | Price 50.02 | Shares 5,044
Planned sale 20 Mar 2026
Value US$187,168.64 | Price 49.32 | Shares 3,795
Planned sale 20 Mar 2026
Value US$296,976.83 | Price 48.20 | Shares 6,161
Planned sale 10 Mar 2026
Value US$17,753.22 | Price 51.02 | Shares 348
Planned sale 10 Mar 2026
Value US$1,495,807.00 | Price 50.45 | Shares 29,652
Proposed sale 10 Mar 2026
Value US$3,372,876.18 | Price 45.06 | Shares 74,853
Planned sale 2 Mar 2026
Value US$168,236.78 | Price 45.47 | Shares 3,700
Planned sale 2 Mar 2026
Value US$57,773.82 | Price 44.44 | Shares 1,300
Planned sale 27 Feb 2026
Value US$171,967.21 | Price 45.72 | Shares 3,761
Planned sale 27 Feb 2026
Value US$168,756.03 | Price 45.13 | Shares 3,739
Planned sale 2 Feb 2026
Value US$34,321.37 | Price 46.63 | Shares 736
Planned sale 2 Feb 2026
Value US$187,067.95 | Price 46.03 | Shares 4,064
Planned sale 2 Feb 2026
Value US$8,830.00 | Price 44.15 | Shares 200
Planned sale 2 Feb 2026
Value US$34,321.37 | Price 46.63 | Shares 736
Planned sale 2 Feb 2026
Value US$187,067.95 | Price 46.03 | Shares 4,064
Planned sale 2 Feb 2026
Value US$8,830.00 | Price 44.15 | Shares 200
Planned sale 2 Feb 2026
Value US$4,723.00 | Price 47.23 | Shares 100
Planned sale 2 Feb 2026
Value US$275,271.32 | Price 46.37 | Shares 5,936
Planned sale 2 Feb 2026
Value US$383,816.43 | Price 45.89 | Shares 8,364
Planned sale 2 Feb 2026
Value US$26,523.00 | Price 44.21 | Shares 600
Planned sale 2 Feb 2026
Value US$4,723.00 | Price 47.23 | Shares 100
Planned sale 2 Feb 2026
Value US$275,271.32 | Price 46.37 | Shares 5,936
Planned sale 2 Feb 2026
Value US$383,816.43 | Price 45.89 | Shares 8,364
Planned sale 2 Feb 2026
Value US$26,523.00 | Price 44.21 | Shares 600
Planned sale 29 Jan 2026
Value US$126,022.40 | Price 45.01 | Shares 2,800
Planned sale 29 Jan 2026
Value US$154,146.65 | Price 44.04 | Shares 3,500
Planned sale 29 Jan 2026
Value US$51,821.28 | Price 43.18 | Shares 1,200
Planned sale 22 Jan 2026
Value US$227,612.00 | Price 45.52 | Shares 5,000
Proposed sale 16 Jan 2026
Value US$1,210,937.40 | Price 40.67 | Shares 29,772
Planned sale 7 Jan 2026
Value US$1,011,298.87 | Price 40.20 | Shares 25,156
Sale 7 Jan 2026
Value US$1,052,784.67 | Price 39.11 | Shares 26,920
Proposed sale 7 Jan 2026
Value US$1,052,784.67 | Price 39.11 | Shares 26,920
Sale 6 Jan 2026
Value US$96,269.69 | Price 38.62 | Shares 2,493
Proposed sale 6 Jan 2026
Value US$96,269.69 | Price 38.62 | Shares 2,493
Planned sale 5 Jan 2026
Value US$16,480.00 | Price 40.00 | Shares 412
Planned sale 2 Jan 2026
Value US$179,187.53 | Price 40.43 | Shares 4,432
Planned sale 2 Jan 2026
Value US$102,681.30 | Price 39.57 | Shares 2,595
Planned sale 2 Jan 2026
Value US$93,072.30 | Price 38.70 | Shares 2,405
Planned sale 30 Dec 2025
Value US$200,407.00 | Price 40.08 | Shares 5,000
Planned sale 30 Dec 2025
Value US$4,036.00 | Price 40.36 | Shares 100
Planned sale 29 Dec 2025
Value US$24,694.98 | Price 41.16 | Shares 600
Planned sale 29 Dec 2025
Value US$381,071.30 | Price 40.54 | Shares 9,400
Planned sale 29 Dec 2025
Value US$703,930.64 | Price 40.93 | Shares 17,200
Planned sale 29 Dec 2025
Value US$1,121,424.20 | Price 40.34 | Shares 27,800
Planned sale 29 Dec 2025
Value US$248,211.10 | Price 41.13 | Shares 6,035
Planned sale 29 Dec 2025
Value US$2,688,552.33 | Price 40.51 | Shares 66,365
Proposed sale 29 Dec 2025
Value US$4,420,500.00 | Price 42.10 | Shares 105,000
Proposed sale 29 Dec 2025
Value US$3,683,750.00 | Price 42.10 | Shares 87,500
Proposed sale 4 Dec 2025
Value US$425,423.00 | Price 42.54 | Shares 10,000
Proposed sale 21 Nov 2025
Value US$984,588.00 | Price 35.80 | Shares 27,500
Sale 15 Sep 2025
Value US$464,034.98 | Price 22.37 | Shares 20,744
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
40,640 -35.6%
109.34
US$2,421,770 		40,640 -35.6% 109.34 US$2,421,770
2026-06-03 2026-06-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
52,490 -44.2%
237.30
US$3,423,799 		52,490 -44.2% 237.30 US$3,423,799
2026-06-03 2026-06-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
4,608 +36.2%
486.22
US$4,141,048 		4,608 +36.2% 486.22 US$4,141,048
2026-06-03 2026-06-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,000 -1.7%
26.20
US$100,000 		1,000 -1.7% 26.20 US$100,000
2026-06-01 2026-06-01 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,501
26.32
US$908,066 		34,501 26.32 US$908,066
2026-06-02 2026-05-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
1,000 -23.2%
26.34
US$100,000 		1,000 -23.2% 26.34 US$100,000
2026-05-27 2026-05-26 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
25,582 -6.8%
26.02
US$665,516 		25,582 -6.8% 26.02 US$665,516
2026-05-27 2026-05-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,478 -8.0%
26.00
US$64,428 		2,478 -8.0% 26.00 US$64,428
2026-05-27 2026-05-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
4,504 -1.2%
26.00
US$117,104 		4,504 -1.2% 26.00 US$117,104
2026-05-18 2026-05-15 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
116 -0.4%
26.00
US$3,016 		116 -0.4% 26.00 US$3,016
2026-05-18 2026-05-15 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,822 -0.5%
26.00
US$47,372 		1,822 -0.5% 26.00 US$47,372
2026-05-15 2026-05-15 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,502
25.95
US$895,327 		34,502 25.95 US$895,327
2026-05-18 2026-05-14 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
15,000 -100.0%
26.22
US$393,354 		15,000 -100.0% 26.22 US$393,354
2026-05-01 2026-04-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,500 -41.7%
25.37
US$190,299 		7,500 -41.7% 25.37 US$190,299
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
300 -2.3%
30.34
US$9,101 		300 -2.3% 30.34 US$9,101
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
300 -2.3%
30.34
US$9,101 		300 -2.3% 30.34 US$9,101
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,200 -14.2%
29.32
US$64,510 		2,200 -14.2% 29.32 US$64,510
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,200 -14.2%
29.32
US$64,510 		2,200 -14.2% 29.32 US$64,510
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
300 -100.0%
31.07
US$9,320 		300 -100.0% 31.07 US$9,320
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
3,348 -91.8%
30.06
US$100,636 		3,348 -91.8% 30.06 US$100,636
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
11,352 -75.7%
29.24
US$331,948 		11,352 -75.7% 29.24 US$331,948
2026-04-01 2026-03-30 PlS Planned sale
Dandekar Atul

CSBO

Officer
790 -7.0%
30.02
US$23,714 		790 -7.0% 30.02 US$23,714
2026-04-01 2026-03-30 PlS Planned sale
Dandekar Atul

CSBO

Officer
6,710 -37.3%
29.26
US$196,305 		6,710 -37.3% 29.26 US$196,305
2026-03-30 2026-03-30 PrS Proposed sale
ATUL DANDEKAR

Officer

Officer
30,000
30.38
US$911,400 		30,000 30.38 US$911,400
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
5,044 -100.0%
50.02
US$252,294 		5,044 -100.0% 50.02 US$252,294
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
3,795 -42.9%
49.32
US$187,169 		3,795 -42.9% 49.32 US$187,169
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
6,161 -41.1%
48.20
US$296,977 		6,161 -41.1% 48.20 US$296,977
2026-03-12 2026-03-10 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
348 -100.0%
51.02
US$17,753 		348 -100.0% 51.02 US$17,753
2026-03-12 2026-03-10 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
29,652 -98.8%
50.45
US$1,495,807 		29,652 -98.8% 50.45 US$1,495,807
2026-03-10 2026-03-10 PrS Proposed sale
HAROLD BERNSTEIN

Officer

Officer
74,853
45.06
US$3,372,876 		74,853 45.06 US$3,372,876
2026-03-03 2026-03-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
3,700 -22.2%
45.47
US$168,237 		3,700 -22.2% 45.47 US$168,237
2026-03-03 2026-03-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
1,300 -7.2%
44.44
US$57,774 		1,300 -7.2% 44.44 US$57,774
2026-03-03 2026-02-27 PlS Planned sale
Dandekar Atul

CSBO

Officer
3,761 -26.4%
45.72
US$171,967 		3,761 -26.4% 45.72 US$171,967
2026-03-03 2026-02-27 PlS Planned sale
Dandekar Atul

CSBO

Officer
3,739 -20.8%
45.13
US$168,756 		3,739 -20.8% 45.13 US$168,756
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
736 -5.4%
46.63
US$34,321 		736 -5.4% 46.63 US$34,321
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
4,064 -22.9%
46.03
US$187,068 		4,064 -22.9% 46.03 US$187,068
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
200 -1.1%
44.15
US$8,830 		200 -1.1% 44.15 US$8,830
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
100 -100.0%
47.23
US$4,723 		100 -100.0% 47.23 US$4,723
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
5,936 -98.3%
46.37
US$275,271 		5,936 -98.3% 46.37 US$275,271
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
8,364 -58.1%
45.89
US$383,816 		8,364 -58.1% 45.89 US$383,816
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
600 -4.0%
44.21
US$26,523 		600 -4.0% 44.21 US$26,523
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
736 -5.4%
46.63
US$34,321 		736 -5.4% 46.63 US$34,321
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
4,064 -22.9%
46.03
US$187,068 		4,064 -22.9% 46.03 US$187,068
2026-02-04 2026-02-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
200 -1.1%
44.15
US$8,830 		200 -1.1% 44.15 US$8,830
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
100 -100.0%
47.23
US$4,723 		100 -100.0% 47.23 US$4,723
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
5,936 -98.3%
46.37
US$275,271 		5,936 -98.3% 46.37 US$275,271
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
8,364 -58.1%
45.89
US$383,816 		8,364 -58.1% 45.89 US$383,816
2026-02-04 2026-02-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
600 -4.0%
44.21
US$26,523 		600 -4.0% 44.21 US$26,523
2026-02-02 2026-01-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
2,800 -21.0%
45.01
US$126,022 		2,800 -21.0% 45.01 US$126,022
2026-02-02 2026-01-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
3,500 -20.8%
44.04
US$154,147 		3,500 -20.8% 44.04 US$154,147
2026-02-02 2026-01-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
1,200 -6.7%
43.18
US$51,821 		1,200 -6.7% 43.18 US$51,821
2026-01-26 2026-01-22 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
5,000 -27.8%
45.52
US$227,612 		5,000 -27.8% 45.52 US$227,612
2026-01-16 2026-01-16 PrS Proposed sale
SEKAR KATHIRESAN

Former Director

Non-Executive Director
29,772
40.67
US$1,210,937 		29,772 40.67 US$1,210,937
2026-01-09 2026-01-07 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
25,156 -100.0%
40.20
US$1,011,299 		25,156 -100.0% 40.20 US$1,011,299
2026-01-08 2026-01-07 S Sale
3.2
Sohn Catherine A.
Non-Executive Director
26,920 -100.0%
39.11
US$1,052,785 		26,920 -100.0% 39.11 US$1,052,785
2026-01-07 2026-01-07 PrS Proposed sale
3.2
CATHERINE SOHN

Director

Non-Executive Director
26,920
39.11
US$1,052,785 		26,920 39.11 US$1,052,785
2026-01-08 2026-01-06 S Sale
3.2
Sohn Catherine A.
Non-Executive Director
2,493 -100.0%
38.62
US$96,270 		2,493 -100.0% 38.62 US$96,270
2026-01-06 2026-01-06 PrS Proposed sale
3.2
CATHERINE SOHN

Director

Non-Executive Director
2,493
38.62
US$96,270 		2,493 38.62 US$96,270
2026-01-06 2026-01-05 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
412 -100.0%
40.00
US$16,480 		412 -100.0% 40.00 US$16,480
2026-01-06 2026-01-02 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
4,432 -100.0%
40.43
US$179,188 		4,432 -100.0% 40.43 US$179,188
2026-01-06 2026-01-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,595 -16.7%
39.57
US$102,681 		2,595 -16.7% 39.57 US$102,681
2026-01-06 2026-01-02 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,405 -13.4%
38.70
US$93,072 		2,405 -13.4% 38.70 US$93,072
2025-12-31 2025-12-30 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
5,000 -27.8%
40.08
US$200,407 		5,000 -27.8% 40.08 US$200,407
2025-12-31 2025-12-30 PlS Planned sale
Dandekar Atul

CSBO

Officer
100 -0.9%
40.36
US$4,036 		100 -0.9% 40.36 US$4,036
2025-12-31 2025-12-29 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
600 -4.4%
41.16
US$24,695 		600 -4.4% 41.16 US$24,695
2025-12-31 2025-12-29 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
9,400 -40.9%
40.54
US$381,071 		9,400 -40.9% 40.54 US$381,071
2025-12-31 2025-12-29 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
17,200 -100.0%
40.93
US$703,931 		17,200 -100.0% 40.93 US$703,931
2025-12-31 2025-12-29 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
27,800 -61.8%
40.34
US$1,121,424 		27,800 -61.8% 40.34 US$1,121,424
2025-12-31 2025-12-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
6,035 -36.5%
41.13
US$248,211 		6,035 -36.5% 41.13 US$248,211
2025-12-31 2025-12-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
66,365 -80.1%
40.51
US$2,688,552 		66,365 -80.1% 40.51 US$2,688,552
2025-12-29 2025-12-29 PrS Proposed sale
HAROLD BERNSTEIN

Officer

Officer
105,000
42.10
US$4,420,500 		105,000 42.10 US$4,420,500
2025-12-29 2025-12-29 PrS Proposed sale
ATUL P DANDEKAR

Officer

Officer
87,500
42.10
US$3,683,750 		87,500 42.10 US$3,683,750
2025-12-04 2025-12-04 PrS Proposed sale
SEKAR KATHIRESAN

Former Board Member
10,000
42.54
US$425,423 		10,000 42.54 US$425,423
2025-11-21 2025-11-21 PrS Proposed sale
SEKAR KATHIRESAN

Former Board Member
27,500
35.80
US$984,588 		27,500 35.80 US$984,588
2025-09-16 2025-09-15 S Sale
2.4
SCHELLER RICHARD H
Non-Executive Director
20,744 -100.0%
22.37
US$464,035 		20,744 -100.0% 22.37 US$464,035
Explore more

More insider trading research around Maze Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America